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A B S T R A C T
The aim of the study was to evaluate the justification of Croatian modification of Bethesda classification after thir-
teen years of its application, answering the question if the subclassification of high-grade squamous intraepithelial le-
sion (HSIL) into cervical intraepithelial lesion (CIN) grade 2 (CIN2) and grade 3 (CIN3) is cytologically real and clini-
cally justified. The retrospective study included 3110 women to whom cervical intraepithelial lesion of different grade
was diagnosed by cytological examination of vaginal-cervical-endocervical (VCE) smear at Department of Clinical Cytol-
ogy, Clinical hospital Osijek in period from 1993 to 2005. 57.1% of women were monitored cytologically and colpo-
scopically, while 42.9% of them had also pathohistological examination. The spontaneous regression of cytological find-
ing was noted in 66.3% of the cases. Moderate dysplasia regressed more often (50.98%) than severe dysplasia (31.3%) and
more rarely than mild dysplasia (70.1%), which was statistically significant (p<0.05). Comparing the first and the most
serious cytological diagnosis during monitoring, it was found that mild dysplasia was also the most serious diagnosis in
80.1% of the cases, while in 19.9% of patients the initial diagnosis progressed into more severe lesion. Moderate dys-
plasia was also the most serious cytological diagnosis in 65.35% of the cases, while it progressed in severe dysplasia in
34.1% of the cases. Moderate dysplasia progressed more often into severe dysplasia than mild dysplasia (34.1% vs.
12.7%), which was statistically significant (p<0.05). Positive predictive value of differential cytological diagnoses mild
(23.7%), moderate (40.3%) and severe (90.1%) dysplasia calculated in relation to histological CIN3+ statistically signifi-
cantly increases for every single diagnosis. Moderate dysplasia and severe dysplasia differ statistically (p>0.05) in their
biological behaviour and histological finding. In fact, 50.9% of moderate dysplasia spontaneously regressed, 14.4% per-
sisted during follow-up, and 59.7% had a histological finding milder than CIN3. Therefore, in almost 65% of moderate
dysplasia lesions it is not justified to apply the same diagnostic therapeutic procedures as for severe lesions, which means
that cytological subclassification of HSIL into moderate dysplasia and severe dysplasia lesions is clinically justified.
Positive predictive value of differential cytological diagnoses mild, moderate and severe dysplasia calculated in relation
to histological CIN3+ statistically significantly increases for every single diagnosis, which also confirms that moderate
dysplasia can be individual diagnostic category, thus the subclassification of HSIL is cytologically possible.
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Introduction
For the purpose of creating an evident and universal
terminology in the field of cervical and vaginal cytology
Division of Cancer Prevention and Control of National
Cancer Institute (NCI) organized a meeting of experts in
Bethesda in 1988, who recommended a uniform termino-
logy classification »The 1988 Bethesda System« (TBS)1
for cervical/vaginal cytological findings on the interna-
tional level. According to the spectrum of precursors to
cervical squamous carcinoma new term has been intro-
duced, squamous intraepithelial lesion (SIL). The aim
was to solve the problem of dual terms (dysplasia, carci-
noma in situ) as well as a problem of semantically incor-
rect term neoplasia (cervical intraepithelial neoplasia).
Respecting the clinical course or progression probability
in invasive form, a low risk category – low grade squ-
amous intraepithelial lesion (LSIL) has been separated
from a high risk category – high grade squamous intra-
epithelial lesion (HSIL), so that LSIL includes a cellular
changes linked with HPV/mild dysplasia/CIN1, while
HSIL includes moderate and severe dysplasia and carci-
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noma in situ/CIN2 and CIN31. Sorting of lesions with dif-
ferent biological behaviour in relation to progression and
regression rate in common HSIL category implicating
the same diagnostically therapy process, brought about a
number of critical remarks2.
The problem of including the moderate dysplasia
(CIN2) in HSIL was pointed out by Audy-Jurkovi} and
associates in November 1990 at the scientific meeting
»Clinical cytology in Croatia«3, modifying classification
Bethesda system for the use in Croatia. The authors sug-
gested to retain, beside SIL degrees, alternative classifi-
cations (dysplasia-carcinoma in situ, i.e. CIN), that has
also been kept in »Zagreb 2002« revision4.
Retrospectively, after 13 years of application the aim
was to evaluate justification of this modification, answer-
ing the question: »Is the HSIL subclassification cytologi-
cally real and clinically justified?«
Materials and Methods
The retrospective study included 3110 women to
whom intraepithelial lesion of cervix of different grade
has been diagnosed by cytological examination of vagi-
nal-cervical-endocervical (VCE) smear at Clinical Cytol-
ogy Department of University Hospital in Osijek in pe-
riod from 1993 to 2005. Women were examined according
to valid diagnostic therapeutic algorithm5. 1175 (57.1%)
examinees were monitored only cytologically (and by
colposcopy), while 1335 (42.9%) also had pathohisto-
logical examination (411 with and 924 without previous
monitoring longer than a year).
In order to determine lesion’s biological behaviour, re-
gression was defined as two or more negative follow-up
cytological findings in a year or more, persistence was de-
fined as two or more abnormal or intermittently abnor-
mal follow-up cytological findings which indicated squ-
amous intraepithelial lesion of different grade (LSIL or
HSIL) in a year or more, while progression was defined
as cytological finding suggesting an invasive lesion.
Positive predictive value (proportion of correctly diag-
nosed by the test relative to all positive tests (true and
false)6 as the best indicator of diagnostic value of differ-
ential cytology were determined based on the compari-
son of the most serious cytological finding with the most
serious pathohistological finding independent on the type
of histological sample.
Results
Spontaneous regression of cytological findings sho-
wed 66.3% of the cases. This percentage was the highest
for mild dysplasia (70.1%) and the lowest for severe
dysplasia (31.35%). The percentage of spontaneous re-
gression of moderate dysplasia was 50.98%. Moderate
dysplasia regressed significantly more often than severe
dysplasia (z=3.385; p=3.56310–4) and significantly mo-
re rarely than mild dysplasia (z=5.113; p=1.58610–7).
Intraepithelial lesion persisted in 33.4% of the cases.
According to the lesion grade, 29.9% of mild dysplasia,
48.5% of moderate dysplasia and 66.4% of severe dys-
plasia persisted.
Progression into invasive lesion was determined in
one case of the first cytological diagnosis of mild dyspla-
sia, in one case of the first cytological diagnosis of moder-
ate dysplasia and in three cases of the first cytological di-
agnosis of severe dysplasia, which makes total of 0.2% of
all cases. History data determined for all above men-
tioned examinees that progression took place in the pe-
riod longer than two years during which patients did not
undergo follow-up cytological examinations (Table 1).
Comparing the first and the most serious cytological
diagnosis in women cytologically monitored longer than
one year, it was found that mild dysplasia was also the
most serious diagnosis in 80.1% of the cases, while in
19.9% of the cases the initial diagnosis mild dysplasia
progressed into more severe lesion, moderate dysplasia
or severe dysplasia. Moderate dysplasia was also the
most serious cytological diagnosis in 65.3% of the cases,
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TABLE 1
BIOLOGICAL BEHAVIOUR OF LESION IN RELATION TO THE FIRST CYTOLOGIC DIAGNOSIS (N=2186)
Natural course
The first cytologic diagnosis
Total
LSIL HSIL favor CIN2 HSIL favor CIN3
Regression
1325 85 40 1450
70.1% 50.9% 31.3% 66.3%
Persistence
565 81 85 731
29.9% 48.5% 66.4% 33.4%
Progression
1 1 3 5
0.1% 0.6% 2.3% 0.2%
Total
1891 167 128 2186
100.0% 100.0% 100.0% 100.0%
LSIL – low grade squamous intraepithelial lesion
HSIL – high grade squamous intraepithelial lesion
CIN2 – cervical intraepithelial neoplasia 2 (moderate dysplasia)
CIN3 – cervical intraepithelial neoplasia 3 (severe dysplasia and carcinoma in situ)
and it progressed into severe dysplasia in 34.1% of the
cases. Moderate dysplasia progressed into severe dyspla-
sia significantly more often than mild dysplasia (34.1%
vs. 12.7%) (z=–7.558, p=2.04710–14) (Table 2).
Pathohistological verification of cytological finding
was done in 1335 patients: aimed biopsy in 726 patients,
cone biopsy in 698 patients and in 153 it was done from
removed uterus. In 1062 patients only one procedure was
applied, and in 273 patients two or more procedures of
pathohistological verification were applied.
Positive predictive value of cytological differential di-
agnosis of severe dysplasia (84.3%) is significantly higher
than that of moderate dysplasia (36.9%) (z=–12.895,
p=2.36210–38) and mild dysplasia (44.3%) (z=–12.736;
p=1.82710–37), but positive predictive values of mild
dysplasia and moderate dysplasia do not differ statisti-
cally (z=1.423; p=0.0773) (Table 3).
In order to better present value of every cytological
differential diagnosis from a clinical standpoint, PPV+
of cytological diagnosis can be calculated in relation to
histological CIN2+, CIN3+ and carcinoma (Table 4).
PPV+ of differential cytology for CIN3+ statistically sig-
nificantly increases with the lesion severity, and for mild
dysplasia was 23.7%, for moderate dysplasia was 40.3%
and for severe dysplasia was 90.1%.
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TABLE 2




The most serious cytological diagnosis
Total




1514 136 240 1 1891
80.1% 7.2% 12.7% 0.1% 100.0%
HSIL favor CIN2
0 109 57 1 167
0% 65.3% 34.1% 0.6% 100.0%
HSIL favor CIN3
0 0 125 3 128
0% 0% 97.7% 2.3% 100.0%
Total
1514 245 422 5 2186
69.3% 11.2% 19.3% 0.2% 100.0%
LSIL – low grade squamous intraepithelial lesion
HSIL – high grade squamous intraepithelial lesion
CIN2 – cervical intraepithelial neoplasia 2 (moderate dysplasia)
CIN3 – cervical intraepithelial neoplasia 3 (severe dysplasia and carcinoma in situ)
TABLE 3
RELATION OF THE MOST SERIOUS CYTOLOGIC AND THE MOST SERIOUS HISTOLOGIC FINDINGS INDEPENDENT ON THE KIND





Negative CIN1 CIN2 CIN3 Carcinoma Ia122 Carcinoma Ia222 Carcinoma
LSIL N 38 101 35 52 1 0 1 228
% 16.7 44.3 15.4 22.8 0.4 0 0.4 100
HSIL favor
CIN2
N 9 25 55 58 1 0 1 149
% 6.0 16.8 36.9 38.9 0.7 0 0.7 100
HSIL favor
CIN3
N 17 29 47 790 21 11 23 938




N 0 0 0 4 5 2 9 20
% 0 0 0 20.0 25.0 10.0 45.0 100
Total 64 155 137 904 28 13 34 1335
LSIL – low grade squamous intraepithelial lesion
HSIL – high grade squamous intraepithelial lesion
CIN1 – cervical intraepithelial neoplasia 1 (mild dysplasia)
CIN2 – cervical intraepithelial neoplasia 2 (moderate dysplasia)
CIN3 – cervical intraepithelial neoplasia 3 (severe dysplasia and carcinoma in situ)
Severe dysplasia was found pathohistologically signif-
icantly more often in cytological diagnosis of moderate
dysplasia (38.9%) than in cytological diagnosis of mild
dysplasia (22.8%) (z=–3.366; p=3.81310–4), but signifi-
cantly more rarely than in cytological diagnosis of severe
dysplasia (38.9% or 84.2%) (z=–12.401; p=1.2610–35).
Invasive lesion was found pathohistologically in 0.8%
of cytological diagnosis of mild dysplasia, and in 1.4% of
cytological diagnosis of moderate dysplasia. The differe-
nce was not statistically significant (z=–0.431; p=0.333).
As for cytological diagnosis of severe dysplasia, invasive
lesion was found pathohistologically in 5.9% of the cases,
which was statistically more often than for moderate dys-
plasia (z=–2.3; p=0.0107) and mild dysplasia (z=–3.132;
p=8.68610–4).
Discussion
Grading of intraepithelial lesion by semiquantitative
criteria like »mild«, »moderate«, »severe«, »low-grade«
and »high-grade« is not objective, namely it depends on
morphologist's subjective estimation, as a consequence of
non-existing of clear and certain morphological criteria
which separate single diagnostic categories. This fact be-
comes more distinctive as there are more possible op-
tions that morphologist can choose. Because of that, each
new classification tends to diminish the number of possi-
ble diagnoses moving from starting three grades of dys-
plasia and carcinoma in situ (CIS) over three grades of
CIN and finally to two grades of SIL. As long as the num-
ber of morphological groups (diagnoses) is too large, the
diagnostic punctuality and reproducibility is low, but on
the other hand, the diminished groups’ number gives too
little information to the gynaecologist to make adequate
decisions concerning further diagnostic and therapeutic
procedure. Therefore, there is a need for classification
with high positive predictive value, diagnostic accuracy
and reproducibility that will give enough data for steady
clinical treatment, also respecting negative consequences
that can be caused by certain diagnostic-therapeutic pro-
cedure.
Although Bethesda System terminology1,7 leaves cy-
tologist freedom to add descriptive terms (as »according
to moderate or severe dysplasia«), Vooijs2 considers that
there is a danger of total abandonment of detailed and
specific description in the end. Grouping together lesions
like moderate (CIN2) and severe dysplasia /CIS (CIN3)
that have different biological behaviour with respect to
the rate of progression, regression and proliferation po-
tential will make more difficult to get better insight in
their real biological nature. Especially with regard to bio-
logical behaviour, there is no ground for categorisation of
moderate dysplasia (CIN2) into lesion of higher risk
grade, as in Bethesda System1,7. Numerous studies sho-
wed that 60% of lesions primarily diagnosed as moderate
dysplasia (CIN2) were minimally atypical or not atypical
after certain follow-up period. 20% of the rest persisted
and 19% progressed into severe dysplasia or CIS, while
1% had characteristics of microinvasive or invasive squa-
mous carcinoma. Thus, 80% of the lesions originally di-
agnosed as moderate dysplasia stays the same or even of
lower grade during follow-up8,9. According to Croatian
algorithm5, changes cytologically diagnosed as moderate
dysplasia (CIN2) require colposcopy and further cytologi-
cal follow-up in four months, except in cases when col-
poscopy points to more severe lesion so the biopsy needs
to be done immediately. Additionally, every case is evalu-
ated individually taking into account age of the patient,
parity, lesion duration and size, visibility of squamoco-
llumnar border and biopsy result if available. Croatian
modification of TBS classification2,4 and Croatian al-
gorithm3 divide (and treat) separately moderate dys-
plasia from HSIL category due to the fact that consider-
ing relative low colposcopy value10,11 in determining his-
tological grade of intraepithelial lesions, it can be ex-
pected that the clinical procedure will soon be the same
for all lesions classified as »high degree SIL«, that way
60% of women with initial diagnosis of moderate dys-
plasia (CIN2) that according to data regresses without
any clinical intervention will be unnecessarily submitted
to more aggressive treatment.
Our results confirm this fact. Moderate dysplasia re-
gressed in 50.98% of the patients which corresponds to
literature data (17 to 57%)12–16. Moderate dysplasia re-
gression was statistically more rare than mild dysplasia
regression (70.1%; 25 to 83% according to literature
data16–21), but significantly more often than severe dys-
plasia regression (31.3%), (p<0.05).
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TABLE 4




LSIL % 39 23.7 0.9
HSIL favor CIN2 % 77.2 40.3 1.3
HSIL favor CIN3 % 95.1 90.1 5.9
Carcinoma planocellulare invasivum % 100 80
CIN2+ – cervical intraepithelial neoplasia 2 (moderate dysplasia) or worse
CIN3+ – cervical intraepithelial neoplasia 3 (severe dysplasia and carcinoma in situ) or worse
Since 50.89% of moderate dysplasia lesions regressed
during the follow-up into negative findings, and addi-
tional 14.4% persisted as the same or milder intraepi-
thelial lesion, that makes total of 65.3% of cytological
moderate dysplasia lesions where it is not justifiable to
apply identical diagnostic therapeutic procedure as for
severe dysplasia lesions, therefore cytological subclassifi-
cation of HSIL into moderate dysplasia and severe dys-
plasia is clinically justifiable.
In order to evaluate cytological diagnostic accuracy in
predicting pathohistology we compared the most serious
cytological diagnosis to the most serious pathohistolo-
gical diagnosis independent on the kind of histological
sample. Cytological diagnosis of severe dysplasia was
confirmed histologically significantly more often (84.2%)
than milder diagnoses (mild dysplasia 44.3% and moder-
ate dysplasia 36.9%) what makes its positive predictive
value significantly higher (p<0.05). But positive predic-
tive value of moderate dysplasia did not significantly dif-
fer from that of mild dysplasia (p>0.05), which is accord-
ing to majority of classifications independent diagnostic
category. PPV+ of differential cytological diagnoses mild,
moderate and severe dysplasia (Table 4) calculated in re-
lation to histological CIN3+ statistically significantly in-
creases for every single diagnosis, which also suggests
possibility of extracting moderate dysplasia from HSIL
category.
CIN3 lesions were found pathohistologically in 22.8%
of cytologically diagnosed mild dysplasia, in 38.9% of cy-
tological moderate dysplasia and in 84.2% of cytological
severe dysplasia. All differences were statistically signifi-
cant (p<0.05). In other words, 59.7% of moderate dys-
plasia had histological finding milder than CIN3, while
the same goes for only 9.9% of severe dysplasia (Table 3).
Additional argument to keep three degrees of CIN
presents actual pathohistological classification of intra-
epithelial lesions, which has three categories, so keeping
the same division in cytology makes possible the compar-
ison of cytological and pathohistological diagnoses.
Conclusion
Cytological subclassification of HSIL to moderate dys-
plasia and severe dysplasia lesions is clinically justified
since they significantly differ in biological behaviour and
histological finding. In fact, 50.9% of moderate dysplasia
spontaneously regressed and 59.7% had histological find-
ing milder than CIN3. On the contrary, 31.3% of severe
dysplasia spontaneously regressed and only 9.9% had
histological finding milder than CIN3.
Positive predictive value of cytological differential di-
agnosis moderate dysplasia is significantly lower (36.9%)
than that of severe dysplasia (84.2%), but it doesn’t differ
significantly from that of mild dysplasia (44.3%). Equ-
ally, PPV+ of differential cytological diagnoses mild,
moderate and severe dysplasia calculated in relation to
histological CIN3+ statistically significantly increases
for every single diagnosis. All of that suggests that mod-
erate dysplasia can be separated as an Individual diag-
nostic category, meaning that subclassification of HSIL is
cytologically possible.
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DA LI JE SUBKLASIFIKACIJA HSIL CITOLO[KI REALNA I KLINI^KI OPRAVDANA?
S A @ E T A K
Cilj rada bio je ocijeniti opravdanost hrvatske modifikacije Bethesda klasifikacije nakon trinaest godina njezine
primjene, odgovaraju}i na pitanje je li subklasifikacija skvamozne intraepitelne lezije visokog stupnja (HSIL) na cer-
vikalnu intraepitelnu neolplaziju (CIN) 2 i CIN3 citolo{ki mogu}a i klini~ki opravdana. Retrospektivnom je studijom
obuhva}eno 3110 ispitanica u kojih je na Odjelu za klini~ku citologiju Klini~ke bolnice Osijek od 1993. do 2005. godine
citolo{kim pregledom vaginalno-cervikalno-endocervikalnih (VCE) razmaza dijagnosticirana plo~asta intraepitelna le-
zija vrata maternice razli~ite te`ine. Samo citolo{ki i kolposkopski pra}eno je 57,1% ispitanica, dok 42,9% uz to ima i
patohistolo{ki pregled. U odre|ivanju biolo{kog pona{anja lezije regresija je definirana s dva ili vi{e negativnih kon-
trolnih citolo{kih nalaza u godinu dana ili du`e, perzistencija s dva ili vi{e abnormalnih ili intermitentno abnormalnih
kontrolnih citolo{kih nalaza koji ukazuju na intraepitelnu plo~astu leziju razli~ite te`ine u godini dana ili du`e, a pro-
gresija citolo{kim nalazima koji upu}uju na invazivnu leziju. Pozitivna prediktivna vrijednost procijenjena je na temelju
usporedbe najte`eg citolo{kog nalaza s najte`im patohistolo{kim nalazom neovisno o histolo{kom uzorku. Do spontane
regresije citolo{kog nalaza je do{lo u 66,3% slu~ajeva. CIN2 je regredirao ~e{}e (50,98%) od CIN3 (31,3%), a rje|e od
CIN1 (70,1%) {to je statisti~ki zna~ajno (p<0.05). Usporedbom prve i najte`e citolo{ke dijagnoze tijekom pra}enja,
na|eno je da je CIN1 ujedno i najte`a dijagnoza u 80,1% ispitanica, a do progresije u te`u leziju do{lo je u 19,9% ispi-
tanica. CIN2 bila je i najte`a citolo{ka dijagnoza u 65,3% ispitanica, a u CIN3 je progredirala u 34,1% ispitanica. CIN2 je
~e{}e progredirao u CIN3 (34,1%) od CIN1 (12,7%, {to je statisti~ki zna~ajno (p<0,05)). PPV+ diferencijalnih citolo{kih
dijagnoza lake (23,7%), srednje te{ke (40,3%) i te{ke displazije (90,1%) izra~unatih u odnosu na histolo{ke CIN3+
statisti~ki zna~ajno raste za svaku pojedinu dijagnozu. Patohistolo{ki je CIN3 na|en ~e{}e kod citolo{ke dijagnoze CIN2
(38,9%) nego kod citolo{ke dijagnoze CIN1 (22,8%), {to je statisti~ki zna~ajno (p<0.05). Dakle, citolo{ke CIN2 i CIN3
lezije me|usobno se statisti~ki zna~ajno razlikuju (p<0.05) po biolo{kom pona{anju i histolo{kom nalazu. Naime, 50,9%
CIN2 spontano je regrediralo u negativan nalaz, 14,4% perzistiralo je nepromijenjeno, a 59,7% imalo je histolo{ki nalaz
manji od CIN3. Prema tome, kod gotovo 65% citolo{kih CIN2 lezija nije opravdano primijeniti istovjetni dijagnosti~ko
terapijski postupak kao za CIN3 lezije, pa je stoga klini~ki opravdana citolo{ka subklasifikacija HSIL na CIN2 i CIN3
lezije. PPV+ diferencijalnih citolo{kih dijagnoza lake, srednje te{ke i te{ke displazije izra~unatih u odnosu na histo-
lo{ke CIN3+ statisti~ki zna~ajno raste za svaku pojedinu dijagnozu, {to tako|er govori u prilog da se srednje te{ka
displazija mo`e izdvojiti kao zasebna dijagnosti~ka kategorija, odnosno da je subklasifikacija HSIL citolo{ki mogu}a.
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